These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6184481)

  • 1. Utility of interferons in clinical radiotherapy.
    Mossman KL; Hill LT; Dritschilo A
    J Natl Med Assoc; 1982 Nov; 74(11):1083-7. PubMed ID: 6184481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiosensitizing drugs in the management of cancer.
    Adams GE
    Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering the response to radiation: sensitizers and protectors.
    Citrin DE; Mitchell JB
    Semin Oncol; 2014 Dec; 41(6):848-59. PubMed ID: 25499642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation modifiers: treatment overview and future investigations.
    Thomas CT; Ammar A; Farrell JJ; Elsaleh H
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons: biological and clinical effects.
    Nelson BE; Borden EC
    Semin Surg Oncol; 1989; 5(6):391-401. PubMed ID: 2480628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale of combining radiation and interferon for the treatment of cervical cancer.
    Angioli R; Sevin BU; Perras JP; Untch M; Hightower RD; Nguyen HN; Steren A; Villani C; Averette HE
    Oncology; 1992; 49(6):445-9. PubMed ID: 1281535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Modifiers.
    Citrin DE
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1041-1055. PubMed ID: 31668205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Increasing the effectiveness of tumor radiotherapy with metronidazole].
    Voronina SS; Pelevina II
    Med Radiol (Mosk); 1977 Jun; 22(6):37-43. PubMed ID: 881955
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer trends: the potential of radiation modifiers.
    Elkon D
    Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Restorative inhibition of radiation injureis by chemical compounds as a method of increasing the effectiveness of the radiotherapy of tumors].
    Pelevina II
    Med Radiol (Mosk); 1977 Feb; 22(2):8-13. PubMed ID: 859396
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
    Milas L; Gregoire V; Hunter N; Kurdoglu B; Mason K; Meyn R
    Adv Exp Med Biol; 1997; 400B():559-64. PubMed ID: 9547604
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferons: rationale for clinical trials in neoplastic disease.
    Borden EC
    Ann Intern Med; 1979 Sep; 91(3):472-9. PubMed ID: 382941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?
    Sagar SM
    Integr Cancer Ther; 2010 Mar; 9(1):5-13. PubMed ID: 20042406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of radiation injury by interferon.
    Dritschilo A; Mossman K; Gray M; Sreevalsan T
    Am J Clin Oncol; 1982 Feb; 5(1):79-82. PubMed ID: 6177232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical chemosensitization by misonidazole and related compounds: a critical evaluation.
    Mulcahy RT; Trump DL
    J Clin Oncol; 1988 Apr; 6(4):569-73. PubMed ID: 3357002
    [No Abstract]   [Full Text] [Related]  

  • 19. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of human interferons and 60cobalt radiation on canine and feline tumour cells-preclinical studies].
    Kessler M; Hammer AS; Bailey MQ; Tempel KH; Matis U
    Zentralbl Veterinarmed A; 1996 Dec; 43(10):599-609. PubMed ID: 9065060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.